Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 971-980 of 1772 for cancer

Edit search filters
  1. Prospective Use Of Philips ISuite For Interventional Procedures

    Rochester, MN

  2. A Dose Escalation Study Of HFB301001 In Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study Of AP160-Complex In Advanced Solid Tumors

    Rochester, MN

  4. A Study To Evaluate Combination Therapy To Treat Newly-diagnosed Diffuse Anaplastic Wilms Tumors And Relapsed Favorable Histology Wilms Tumors A Study Of Combination Chemotherapy For Patients With Newly Diagnosed DAWT And Relapsed FHWT

    Rochester, MN

  5. Study Of Relacorilant In Combination With Pembrolizumab For Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production

    Rochester, MN

  6. Ease Aromatase Inhibitor-induced Musculoskeletal Symptoms

    Rochester, MN

  7. JAB-21822 Activity In Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Personalized Neoantigen Peptide-Based Vaccine In Combination With Pembrolizumab For Treatment Of Advanced Solid Tumors

    Jacksonville, FL

  9. Advance Care Planning: Promoting Effective And Aligned Communication In The Elderly

    Rochester, MN

  10. A Study To Assess LXH254 In Patients With Previously Treated Unresectable Or Metastatic BRAFV600 Or NRAS Mutant Melanoma

    Rochester, MN

.

Mayo Clinic Footer